{"disease":{"id":"neuroendocrine-gastroenteropancreatic-tumour","name":"neuroendocrine gastroenteropancreatic tumour"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07185672","title":"PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":162,"lead_sponsor_name":"Tata Memorial Hospital","has_results":false},{"nct_id":"NCT04837885","title":"Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":23,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}